Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Futura Medical Temettü

Temettü kriter kontrolleri 0/6

Futura Medical does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi	2.3%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Hisse başına kazanç	-UK£0.012
Temettü verim tahmini	0%

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)

Sep 13

We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Apr 17

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Jan 05

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

May 10

We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

Jan 10

What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Dec 21

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if FUM's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if FUM's dividend payments have been increasing.

Piyasaya Karşı Temettü Getirisi

Futura Medical Piyasaya Karşı Temettü Getirisi

FUM temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (FUM)	n/a
Pazarın Alt %25'i (GB)	2.1%
Pazarın En İyi %25'i (GB)	5.5%
Sektör Ortalaması (Pharmaceuticals)	2.3%
Analist tahmini (FUM) (3 yıla kadar)	0%

Önemli Temettü: Şirket yakın zamanda herhangi bir ödeme bildirmediğinden FUM şirketinin temettü getirisi, temettü ödeyenlerin en alttaki %25'lik kısmına göre değerlendirilemiyor.

Yüksek Temettü: Unable to evaluate FUM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate FUM's payout ratio to determine if its dividend payments are covered by earnings.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as FUM has not reported any payouts.

Futura Medical Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)

New minor risk - Financial position

New minor risk - Share price stability

Futura Medical plc Announces Update on Us Launch Eroxon's Availability on Amazon and in Stores

Futura Medical plc to Report First Half, 2024 Results on Sep 10, 2024

Futura Medical plc, Annual General Meeting, Jun 20, 2024

We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

New minor risk - Financial data availability

Futura Medical plc to Report Fiscal Year 2023 Results on Apr 10, 2024

New major risk - Share price stability

Futura Medical plc Announces Appointment of Roy Davis as Non-Executive Director

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

New minor risk - Share price stability

New minor risk - Market cap size

Eroxon® Granted Marketing Authorisation in Mexico

Futura Medical plc to Report First Half, 2023 Results on Sep 18, 2023

Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

Less than half of directors are independent

Futura Medical plc Announces Board Changes

New minor risk - Shareholder dilution

Futura Medical plc's Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction

Futura Medical plc, Annual General Meeting, Jun 22, 2023

We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

Price target increased to UK£1.21

Futura Medical plc Announces Application to the US FDA for MED3000

We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Futura Medical plc to Report First Half, 2022 Results on Sep 13, 2022

Price target increased to UK£1.21

Futura Medical plc Prepares for Initial Launches of MED3000

Futura Medical plc, Annual General Meeting, Jun 28, 2022

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

Less than half of directors are independent

Futura Medical plc to Report Fiscal Year 2021 Results on Apr 26, 2022

We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

Futura Medical plc Provides an Update on Good Progress with Its Regulatory and Commercial Activities for MED3000

Futura Medical plc Announces First Patient Visit in Med3000 Confirmatory Study

Price target increased to UK£0.64

Futura Medical plc Receives Recommendation for Approval

Futura Medical plc announced that it has received £1.5 million in funding from Atlantis Investment Management Limited

New 90-day high: UK£0.21

Futura Medical plc Enters into A Licensing Agreement with Pride Century Ventures

New 90-day high: UK£0.20

What We Learned About Futura Medical's (LON:FUM) CEO Compensation

First half earnings released

Futura Medical plc to Report First Half, 2020 Results on Sep 16, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin